4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001944119-25-000012
CHIEF FINANCIAL OFFICER sold 6,609 shares at an average $108.38 ($716,261)
- CHIEF FINANCIAL OFFICER acquired 1,246 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Feeley Kevin · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,246 | $32.67 | $40,707 | 10,001 | D |
| 2025-09-30 | Sale : show line 2 in the form 10b5-1 | −344 | $105.24 | $36,203 | 9,657 | D |
| 2025-09-30 | Sale : show line 3 in the form 10b5-1 | −387 | $106.86 | $41,354 | 9,270 | D |
| 2025-09-30 | Sale : show line 4 in the form 10b5-1 | −2,715 | $107.68 | $292,361 | 6,555 | D |
| 2025-09-30 | Sale : show line 5 in the form 10b5-1 | −2,152 | $108.67 | $233,851 | 4,403 | D |
| 2025-09-30 | Sale : show line 6 in the form 10b5-1 | −421 | $110.05 | $46,330 | 3,982 | D |
| 2025-09-30 | Sale : show line 7 in the form 10b5-1 | −520 | $111.93 | $58,204 | 3,462 | D |
| 2025-09-30 | Sale : show line 8 in the form 10b5-1 | −70 | $113.68 | $7,958 | 3,392 | D |
| Open-market sales · 6,609 sh · avg $108.38 · $716,261 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (Right to Buy) | −1,246 | 4,982 | D |
Loading xslF345X05/form4-10012025_081020.xml…